← Back to all trials
Recruiting
NCT07397325
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Conditions: Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Sex: Female
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 60
Sponsor: Applied Biology, Inc.
Location: Hospital Samel Manaus
Summary
Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with stage I or stage II breast cancer
* Scheduled but not begun, at least 4 cycles of taxane and/or anthracycline-based chemotherapy.
* Ages 18-65
* Able to give informed consent
Exclusion Criteria:
* Resting blood pressure outside the range of 105-140/ 55-99
* Uncontrolled or severe hypertension
* Female pattern hair loss or hair loss disorder
* Folliculitis
* Scalp psoriasis
* Seborrheic dermatitis
* Inflammatory scalp conditions such as lichen planopillaris
* Subjects wearing wigs prior to chemotherapy
* Use of MAO inhibitors
* Unable to provide consent or make allotted clinical visits
Source: ClinicalTrials.gov (NCT07397325). StuddyBuddy aggregates publicly available trial information.
